Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
Conditions:   High-risk Prostate Cancer;   Prostate Cancer Interventions:   Drug: HSV-Tk;   Drug: Valacyclovir;   Drug: Bicalutamide;   Drug: Leuprolide Acetate;   Radiation: Brachytherapy, External beam radiotherapy;   Procedure: Radical prostatectomy Sponsor:   The Methodist Hospital System Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2018 Category: Research Source Type: clinical trials